Cargando…
Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in Israel
IMPORTANCE: A correlation between antibody levels and risk of infection has been demonstrated for the wild-type, Alpha, and Delta SARS-COV-2 variants. High rates of breakthrough infections by the Omicron variant emphasized the need to investigate whether the humoral response elicited by mRNA vaccine...
Autores principales: | Gilboa, Mayan, Gonen, Tal, Barda, Noam, Cohn, Shelly, Indenbaum, Victoria, Weiss-Ottolenghi, Yael, Amit, Sharon, Asraf, Keren, Joseph, Gili, Levin, Tal, Kanaaneh, Yara, Aydenzon, Alex, Canetti, Michal, Freedman, Laurence, Zuckerman, Neta, Mendelson, Ella, Doolman, Ram, Kreiss, Yitshak, Regev-Yochay, Gili, Lustig, Yaniv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208153/ https://www.ncbi.nlm.nih.gov/pubmed/37219906 http://dx.doi.org/10.1001/jamanetworkopen.2023.14757 |
Ejemplares similares
-
Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose
por: Canetti, Michal, et al.
Publicado: (2022) -
Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up
por: Canetti, Michal, et al.
Publicado: (2022) -
Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up
por: Canetti, Michal, et al.
Publicado: (2023) -
Immunogenicity and Reactogenicity of Coadministration of COVID-19 and Influenza Vaccines
por: Gonen, Tal, et al.
Publicado: (2023) -
Comparing immunogenicity and efficacy of two different mRNA-based COVID-19 vaccines as a fourth dose; six-month follow-up, Israel, 27 December 2021 to 24 July 2022
por: Barda, Noam, et al.
Publicado: (2022)